世界のmRNA癌ワクチン・治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV03858)
◆英語タイトル:Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV03858
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはmRNA癌ワクチン・治療薬の世界市場について調査・分析した資料です。種類別(腺癌、粘液性癌、腺扁平上皮癌)の市場規模、用途別(感染症、がん、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別mRNA癌ワクチン・治療薬の競争状況、市場シェア
・世界のmRNA癌ワクチン・治療薬市場:種類別市場規模 2015年-2020年(腺癌、粘液性癌、腺扁平上皮癌)
・世界のmRNA癌ワクチン・治療薬市場:種類別市場規模予測 2021年-2026年(腺癌、粘液性癌、腺扁平上皮癌)
・世界のmRNA癌ワクチン・治療薬市場:用途別市場規模 2015年-2020年(感染症、がん、その他)
・世界のmRNA癌ワクチン・治療薬市場:用途別市場規模予測 2021年-2026年(感染症、がん、その他)
・北米のmRNA癌ワクチン・治療薬市場分析:米国、カナダ
・ヨーロッパのmRNA癌ワクチン・治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのmRNA癌ワクチン・治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のmRNA癌ワクチン・治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのmRNA癌ワクチン・治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market
The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ 780.5 million by 2026, from US$ 213.7 million in 2020, at a CAGR of 24.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Cancer Vaccines and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Cancer Vaccines and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Cancer Vaccines and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Cancer Vaccines and Therapeutics market.

Global mRNA Cancer Vaccines and Therapeutics Scope and Market Size
mRNA Cancer Vaccines and Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Cancer Vaccines and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas

Market segment by Application, split into
Infectious Disease
Cancer
Other

Based on regional and country-level analysis, the mRNA Cancer Vaccines and Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global mRNA Cancer Vaccines and Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2015-2026)
2.2 Global mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Market Size
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2019
3.5 Key Players mRNA Cancer Vaccines and Therapeutics Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2021-2026)

5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2015-2026)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2015-2026)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

(2015-2020)
(2015-2020)
.4 mRNA Cancer Vaccines and Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
(2015-2020)
(2015-2020)
.4 mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
.4 mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
8Key Players Profiles
8.1 Moderna Therapeutics
8.1.1 Moderna Therapeutics Company Details
8.1.2 Moderna Therapeutics Business Overview
8.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
8.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020))
8.1.5 Moderna Therapeutics Recent Development
8.2 CureVac
8.2.1 CureVac Company Details
8.2.2 CureVac Business Overview
8.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
8.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.2.5 CureVac Recent Development
8.3 Translate Bio
8.3.1 Translate Bio Company Details
8.3.2 Translate Bio Business Overview
8.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
8.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.3.5 Translate Bio Recent Development
8.4 BioNTech
8.4.1 BioNTech Company Details
8.4.2 BioNTech Business Overview
8.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
8.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.4.5 BioNTech Recent Development
8.5 Sangamo Therapeutics
8.5.1 Sangamo Therapeutics Company Details
8.5.2 Sangamo Therapeutics Business Overview
8.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
8.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.5.5 Sangamo Therapeutics Recent Development
8.6 Argos Therapeutics
8.6.1 Argos Therapeutics Company Details
8.6.2 Argos Therapeutics Business Overview
8.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
8.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.6.5 Argos Therapeutics Recent Development
8.7 In-Cell-Art
8.7.1 In-Cell-Art Company Details
8.7.2 In-Cell-Art Business Overview
8.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
8.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.7.5 In-Cell-Art Recent Development
8.8 eTheRNA
8.8.1 eTheRNA Company Details
8.8.2 eTheRNA Business Overview
8.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
8.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.8.5 eTheRNA Recent Development
8.9 Ethris
8.9.1 Ethris Company Details
8.9.2 Ethris Business Overview
8.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
8.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.9.5 Ethris Recent Development
8.10 Tiba Biotechnology
8.10.1 Tiba Biotechnology Company Details
8.10.2 Tiba Biotechnology Business Overview
8.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
8.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.10.5 Tiba Biotechnology Recent Development

9Analyst’s Viewpoints/Conclusions

10Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Disclaimer
10.3 Author Details

...

【掲載企業】

Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のmRNA癌ワクチン・治療薬市場2026:インサイト・予測(Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。